Literature DB >> 22581475

Typical renal-coloboma syndrome phenotype in a patient with a submicroscopic deletion of the PAX2 gene.

Kucinskas Laimutis1, Craig Jackson, Xinjie Xu, Berta Warman, Rudaitis Sarunas, Irena Andriuskeviciute, Pundziene Birute, Lisa A Schimmenti, Gordana Raca.   

Abstract

We present a patient with optic nerve hypoplasia, secondary strabismus, mild deafness, abnormal external ear helices, and renal hypoplasia. The clinical phenotype was consistent with renal-coloboma syndrome, but no point mutation in the PAX2 gene could be identified. High-resolution array comparative genomic hybridization (aCGH) analysis showed that this patient has a submicroscopic deletion on chromosome 10, affecting the entire coding region of the PAX2 gene. This finding provided the molecular confirmation of the patient's clinical diagnosis and showed that, in addition to point mutations, deletions of the PAX2 gene contribute to the etiology of the renal-coloboma syndrome.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22581475      PMCID: PMC4098919          DOI: 10.1002/ajmg.a.35342

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  16 in total

1.  Localisation of a 10q breakpoint within the PAX2 gene in a patient with a de novo t(10;13) translocation and optic nerve coloboma-renal disease.

Authors:  K Narahara; E Baker; S Ito; Y Yokoyama; S Yu; D Hewitt; G R Sutherland; M R Eccles; R I Richards
Journal:  J Med Genet       Date:  1997-03       Impact factor: 6.318

2.  Differential regulation of the human Wilms tumour suppressor gene (WT1) promoter by two isoforms of PAX2.

Authors:  M J McConnell; H E Cunliffe; L J Chua; T A Ward; M R Eccles
Journal:  Oncogene       Date:  1997-06-05       Impact factor: 9.867

3.  Update of PAX2 mutations in renal coloboma syndrome and establishment of a locus-specific database.

Authors:  Matthew Bower; Rémi Salomon; Judith Allanson; Corinne Antignac; Francesco Benedicenti; Elisa Benetti; Gil Binenbaum; Uffe B Jensen; Pierre Cochat; Stephane DeCramer; Joanne Dixon; Regen Drouin; Marni J Falk; Holly Feret; Robert Gise; Alasdair Hunter; Kisha Johnson; Rajiv Kumar; Marie Pierre Lavocat; Laura Martin; Vincent Morinière; David Mowat; Luisa Murer; Hiep T Nguyen; Gabriela Peretz-Amit; Eric Pierce; Emily Place; Nancy Rodig; Ann Salerno; Sujatha Sastry; Tadashi Sato; John A Sayer; Gerard C P Schaafsma; Lawrence Shoemaker; David W Stockton; Wen-Hann Tan; Romano Tenconi; Philippe Vanhille; Abhay Vats; Xinjing Wang; Berta Warman; Richard G Weleber; Susan M White; Carolyn Wilson-Brackett; Dina J Zand; Michael Eccles; Lisa A Schimmenti; Laurence Heidet
Journal:  Hum Mutat       Date:  2012-01-31       Impact factor: 4.878

4.  PAX2 gene mutation in a family with isolated renal hypoplasia.

Authors:  Kaori Nishimoto; Kazumoto Iijima; Taku Shirakawa; Kousaku Kitagawa; Kenichi Satomura; Hajime Nakamura; Norishige Yoshikawa
Journal:  J Am Soc Nephrol       Date:  2001-08       Impact factor: 10.121

5.  Primary renal hypoplasia in humans and mice with PAX2 mutations: evidence of increased apoptosis in fetal kidneys of Pax2(1Neu) +/- mutant mice.

Authors:  S Porteous; E Torban; N P Cho; H Cunliffe; L Chua; L McNoe; T Ward; C Souza; P Gus; R Giugliani; T Sato; K Yun; J Favor; M Sicotte; P Goodyer; M Eccles
Journal:  Hum Mol Genet       Date:  2000-01-01       Impact factor: 6.150

6.  Genomic structure of the human PAX2 gene.

Authors:  P Sanyanusin; J H Norrish; T A Ward; A Nebel; L A McNoe; M R Eccles
Journal:  Genomics       Date:  1996-07-01       Impact factor: 5.736

7.  Autosomal dominant optic nerve colobomas, vesicoureteral reflux, and renal anomalies.

Authors:  L A Schimmenti; M E Pierpont; B L Carpenter; C E Kashtan; M R Johnson; W B Dobyns
Journal:  Am J Med Genet       Date:  1995-11-06

8.  WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2.

Authors:  Maria Teresa Discenza; Shujie He; Tae Ho Lee; Lee Lee Chu; Brad Bolon; Paul Goodyer; Michael Eccles; Jerry Pelletier
Journal:  Oncogene       Date:  2003-11-06       Impact factor: 9.867

9.  Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux.

Authors:  P Sanyanusin; L A Schimmenti; L A McNoe; T A Ward; M E Pierpont; M J Sullivan; W B Dobyns; M R Eccles
Journal:  Nat Genet       Date:  1995-04       Impact factor: 38.330

10.  Pax-2 controls multiple steps of urogenital development.

Authors:  M Torres; E Gómez-Pardo; G R Dressler; P Gruss
Journal:  Development       Date:  1995-12       Impact factor: 6.868

View more
  3 in total

1.  A novel truncating PAX2 mutation in a boy with renal coloboma syndrome with focal segmental glomerulosclerosis causing rapid progression to end-stage kidney disease.

Authors:  Ken Saida; Koichi Kamei; Naoya Morisada; Masao Ogura; Kentaro Ogata; Kentaro Matsuoka; Kandai Nozu; Kazumoto Iijima; Shuichi Ito
Journal:  CEN Case Rep       Date:  2019-09-19

2.  A novel PAX2 heterozygous mutation in a family with Papillorenal syndrome: A case report and review of the literature.

Authors:  Shixue Liu; Peijun Zhang; Jihong Wu; Qing Chang
Journal:  Am J Ophthalmol Case Rep       Date:  2021-04-22

Review 3.  New PAX2 heterozygous mutation in a child with chronic kidney disease: a case report and review of the literature.

Authors:  Li Zhang; Shu-Bo Zhai; Leng-Yue Zhao; Yan Zhang; Bai-Chao Sun; Qing-Shan Ma
Journal:  BMC Nephrol       Date:  2018-09-21       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.